Human intrahepatic regulatory T cells are functional, require IL‐2 from effector cells for survival, and are susceptible to Fas ligand‐mediated apoptosis
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Regulatory T cells (T reg) suppress T effector cell proliferation and maintain immune homeostasis. Autoimmune liver diseases persist despite high frequencies of T reg in the liver, suggesting that the local hepatic microenvironment might affect T reg stability, survival, and function. We hypothesized that interactions between T reg and endothelial cells during recruitment and then with epithelial cells within the liver affect T reg stability, survival, and function. To model this, we explored the function of T reg after migration through human hepatic sinusoidal‐endothelium (postendothelial migrated T reg[PEM T reg]) and the effect of subsequent interactions with cholangiocytes and local proinflammatory cytokines on survival and stability of T reg. Our findings suggest that the intrahepatic microenvironment is highly enriched with proinflammatory cytokines but deficient in the T reg survival cytokine interleukin (IL)‐2. Migration through endothelium into a model mimicking the inflamed liver microenvironment did not affect T reg stability; however, functional capacity was reduced. Furthermore, the addition of exogenous IL‐2 enhanced PEM T reg phosphorylated STAT5 signaling compared with PEMCD8. CD4 and CD8 T cells are the main source of IL‐2 in the inflamed liver. Liver‐infiltrating T reg reside close to bile ducts and coculture with cholangiocytes or their supernatants induced preferential apoptosis of T reg compared with CD8 effector cells. T reg from diseased livers expressed high levels of CD95, and their apoptosis was inhibited by IL‐2 or blockade of CD95.Conclusion: Recruitment through endothelium does not impair T reg stability, but a proinflammatory microenvironment deficient in IL‐2 leads to impaired function and increased susceptibility of T reg to epithelial cell‐induced Fas‐mediated apoptosis. These results provide a mechanism to explain T reg dysfunction in inflamed tissues and suggest that IL‐2 supplementation, particularly if used in conjunction with T reg therapy, could restore immune homeostasis in inflammatory and autoimmune liver disease. (H epatology 2016;64:138–150)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669 · cited 1×
“(9,10) Treg are highly sensitive to CD95-mediated apoptosis,((11)) and interleukin (IL)-2-dependent phosphorylation of STAT5 is crucial for their proliferation, differentiation, and survival.((12)) We reported previously that many intrahepatic Treg lack evidence of STAT5 phosphorylation, suggesting that the inflammato…”
BackgroundTrans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4
Qureshi, O. S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E. M., Baker, J., Jeffery, L. E., Kaur, S., Briggs, Z., et al. (2011) · Science · doi:10.1126/science.1202947 · Cited by 1,860 · cited 1×
“CTLA-4 interacts with and removes CD80/CD86 from dendritic cells by way of transendocytosis, resulting in impaired costimulation via CD28 and is thus critical for Treg function.((30)) Overall, LITreg are equipped with key surface markers and intracellular cytokines required to execute their suppressive capacity.”
BackgroundThe aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J.-C., & Stockinger, B. (2008) · Nature · doi:10.1038/nature06881 · Cited by 1,634
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
Bluestone, J. A., Buckner, J. H., Fitch, M., Gitelman, S. E., Gupta, S., Hellerstein, M. K., Herold, K. C., Lares, A., Lee, M. R., Li, K., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad4134 · Cited by 1,033 · cited 1×
“Therapeutic modulation of tissue resident Treg has potential for treating autoimmune liver diseases.((17,18)) Treg enter the liver from blood via hepatic sinusoids((5)) before being localized within the liver in response to signals from the hepatic stromal compartment, hepatocytes, and cholangiocytes.”
BackgroundCurbishley, S. M., Eksteen, B., Gladue, R. P., Lalor, P., & Adams, D. H. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62060-3 · Cited by 141
Self-citation
Cited by
The challenges of primary biliary cholangitis: What is new and what needs to be done
Terziroli Beretta-Piccoli, B., Mieli-Vergani, G., Vergani, D., Vierling, J. M., Adams, D., Alpini, G., Banales, J. M., Beuers, U., Björnsson, E., Bowlus, C., et al. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102328 · Cited by 114
Self-citationSpatial transcriptomics identifies enriched gene expression and cell types in human liver fibrosis
Chung, B. K., Øgaard, J., Reims, H. M., Karlsen, T. H., & Melum, E. (2022) · Hepatology Communications · doi:10.1002/hep4.2001 · Cited by 85
Jeffery, H. C., Hunter, S., Humphreys, E. H., Bhogal, R., Wawman, R. E., Birtwistle, J., Atif, M., Bagnal, C. J., Rodriguez Blanco, G., Richardson, N., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800455 · Cited by 35
Self-citationFunctional heterogeneity of CD4+ T cells in liver inflammation
Muscate, F., Woestemeier, A., & Gagliani, N. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00881-w · Cited by 32
Metadata
- Authors
- Chen, Y., Jeffery, H. C., Hunter, S., Bhogal, R., Birtwistle, J., Braitch, M. K., Roberts, S., Ming, M., Hannah, J., Thomas, C., Adali, G., Hübscher, S. G., Syn, W., Afford, S., Lalor, P. F., Adams, D. H., & Oo, Y. H.
- Venue
- Hepatology
- Published
- 2016-04-15
- Volume
- 64
- Issue
- 1
- Pages
- 138-150
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W2296539228
- Cited by
- 86
- References
- 5
- FWCI
- 7.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.